Supplements and pre-eclampsia
This article was originally published in The Tan Sheet
"Concomitant supplementation with vitamin C and vitamin E does not prevent pre-eclampsia in women at high risk, but does increase the rate of babies born with a low birthweight," according to a study published online by The Lancet March 30. The randomized, placebo-controlled trial enrolled 2,410 women identified as at increased risk of pre-eclampsia and who were assigned either 1,000 mg vitamin C and 400 IU vitamin E daily or placebo. Pre-eclampsia rates did not differ between the treatment group (15%) and placebo (16%), but more low birthweight babies were born to those treated than those on placebo (28% versus 4%). "As such, use of these high-dose antioxidants is not justified in pregnancy," Lucilla Poston, St. Thomas' Hospital, London, et al., conclude. "The daily doses of vitamin C and vitamin E that we gave were below the maximum recommended intake in pregnant women," they note...
You may also be interested in...
Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.
The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.
Bayer notes “significant headwinds" from pandemic hitting its 2020 results likely will continue in 2021, when it t expects core earnings per share slightly below 2020 levels. While noting slumping revenues across its divisions, Bayer said an exception its consumer health business.